The PRIME Theory of motivation and its application to smoking ...

The PRIME Theory of motivation and its application to smoking ...

E-cigarette use in England: Latest trends from the Smoking Toolkit Study Dr Jamie Brown University College London Dr Emma Beard, Dr Daniel Kotz, Prof Susan Michie & Prof Robert West SSA, York, November 2014 Financial disclosure 1. Funding sources for presented work Cancer Research UK, English Department of Health & Pfizer funded data collection for this study, and at outset data collection for the Smoking Toolkit Study was supported by GlaxoSmithKline & Johnson and Johnson Funders had no final role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication 2. Industry funding to the investigators

JB, DK & EB have all received unrestricted research grants from Pfizer; RW undertakes research, consultancy & receives fees for speaking from companies that manufacture smoking cessation medications (Pfizer, J&J, McNeil, GSK, Nabi, Novartis, and Sanofi-Aventis); there are no other financial relationships with any organisations that might have an interest in the work, particularly e-cigarette companies Outline I. Real-world effectiveness of e-cigarettes when used to aid smoking cessation II. Trends in e-cigarette use and other tobacco control indicators in England 3 Outline I. Real-world effectiveness of e-cigarettes when used to aid smoking cessation II. Trends in e-cigarette use and other tobacco control indicators in England

4 E-cigarettes and smoking cessation E-cigarettes have rapidly become popular 10% of US smokers in 2013 (King et al 2014) & 20% of English smokers in 2014 (West & Brown 2014) Majority use to try and quit or cut down Hajek et al 2014 Reduce craving and withdrawal Bullen et al 2010; Vansickel et al 2010; Dawkins et al 2012; Goniewicz et al 2013; Vansickel & Eissenberg 2013 Two RCTs suggested e-cigarettes may aid smoking cessation Bullen et al 2013; Caponnetto et al 2013 5 Why complement randomised trials? 1. Can only test limited range of products which may be obsolete by the end of the trial 2. Take a long time to report and regulatory

decisions are urgent Borland 2011; Cobb et al. 2011, 2013; Etter, 2013; Flouris et al 2010; Hajek et al 2013; The Lancet, 2013 3. Will exclude all smokers who are not willing to volunteer or to receive another product 4. Cannot tell what happens when no health professionals are involved 6 Objective To assess the real-world effectiveness of ecigarettes when used in a quit attempt, compared with using nothing or licensed nicotine products bought over the counter among the general population, after adjusting for important confounders Existing studies have produced mixed results Etter 2010; Etter & Bullen 2011; Foulds et al 2011; Siegel et al 2011; Dawkins et al 2013; Farsalinos et al 2013; Goniewicz et al 2013; Etter & Bullen 2014; Etter & Bullen 2014; Vickerman et al 2013; Adkison et al

2013; Borderud et al 2014 7 Objective To assess the real-world effectiveness of ecigarettes when used in a quit attempt, compared with using nothing or licensed nicotine products bought over the counter among the general population, after adjusting for important confounders Existing studies have produced mixed results Etter 2010; Etter & Bullen 2011; Foulds et al 2011; Siegel et al 2011; Dawkins et al 2013; Farsalinos et al 2013; Goniewicz et al 2013; Etter & Bullen 2014; Etter & Bullen 2014; Vickerman et al 2013; Adkison et al 2013; Borderud et al 2014 8 Objective To assess the real-world effectiveness of ecigarettes when used in a quit attempt, compared with using nothing or licensed nicotine products bought over the counter among the general population, after adjusting for important confounders Existing studies have produced mixed results Etter 2010; Etter & Bullen 2011; Foulds et al 2011;

Siegel et al 2011; Dawkins et al 2013; Farsalinos et al 2013; Goniewicz et al 2013; Etter & Bullen 2014; Etter & Bullen 2014; Vickerman et al 2013; Adkison et al 2013; Borderud et al 2014 9 Objective To assess the real-world effectiveness of ecigarettes when used in a quit attempt, compared with using nothing or licensed nicotine products bought over the counter among the general population, after adjusting for important confounders Existing studies have produced mixed results Etter 2010; Etter & Bullen 2011; Foulds et al 2011; Siegel et al 2011; Dawkins et al 2013; Farsalinos et al 2013; Goniewicz et al 2013; Etter & Bullen 2014; Etter & Bullen 2014; Vickerman et al 2013; Adkison et al 2013; Borderud et al 2014 10 Study design and sampling Cross-sectional household surveys of representative samples of adults in England ( www.smokinginengland.info)

Each month new sample of ~ 1800 adults (16+) selected by random location sampling Fidler et al., 2011 Study population and measures Between July 2009 and Feb 2014 6,134 smokers who had tried to stop in the past 12 months using no aid, NRT-OTC or ecigarettes Excluded using both (n=73), and prescription medication or beh support with NRT-OTC (n=173) or e-cigarettes (n=25) 3,477 used no aid 1,922 used NRT-OTC 464 used ecigarette

12 Study population and measures Between July 2009 and Feb 2014 6,134 smokers who had tried to stop in the past 12 months using no aid, NRT-OTC or ecigarettes Excluded using both (n=73), and prescription medication or beh support with NRT-OTC (n=173) or e-cigarettes (n=25) 3,477 used no aid 1,922 used NRT-OTC 464 used ecigarette How many still not

smoking? Is there a difference after adjusting for range of factors? e.g. dependence and time since quit attempt 13 % s e lf - r e p o r t e d s t il l n o t s m o k in g Results: unadjusted analysis ** 30.0 25.0 20.0 20.0 15.0

E-cigarette users were more likely not to be smoking than those using NRT bought over the counter and those using nothing 15.4 10.1 10.0 5.0 0.0 No aid NRT E-cigs ** Significantly different from both other groups 14 Characteristics by quitting method Compared with smokers using e-cigarettes:

100 % 80 60 40 Nothing NRT Ecigarettes 20 M e a n r a t in g ( 0 - 5 ) 0 3 2 Nothing NRT

1 0 E-cigarettes No aid: had lower SES less likely to have quit recently or to have begun attempt gradually were less dependent NRT-OTC: were older had lower SES less likely to have quit recently were more dependent 15 Odds ratio After adjusting for confounders 3

2.8 2.6 2.4 2.2 2 1.8 1.6 1.4 1.2 1 The odds of e-cigarette users still being abstinent were 61% greater than those using nothing and 63% greater than those using NRT bought overthe-counter Vs No aid Vs NRT-OTC 16 Limitations Cannot rule out unmeasured confounding factor

However, external validity greater than RCTs Longitudinal studies in general population adjusting for baseline characteristics would be valuable No biochemical verification Misreporting low in population surveys (Wong et al 2012) Limitations Cannot rule out unmeasured confounding factor However, external validity greater than RCTs Longitudinal studies in general population adjusting for baseline characteristics would be valuable No biochemical verification Misreporting low in population surveys (Wong et al 2012) NRT-OTC & e-cigarettes treated homogenously Conclusion Among English adult smokers in the real world stopping without professional support, those who use e-cigarettes appear more likely to remain abstinent than those who use a licensed NRT product bought over-the-counter or no aid to cessation

This difference persists after adjusting for a wide range of smoker characteristics such as nicotine dependence 19 Outline I. Real-world effectiveness of e-cigarettes when used to aid smoking cessation II. Trends in e-cigarette use and other tobacco control indicators in England 20 Trends in e-cigarette use and other tobacco control indicators in England To monitor e-cigarette prevalence and characterise use over time To assess how far any changes in use are accompanied by changes in: key performance indicators for tobacco control

smoking prevalence uptake in young adults smoking cessation rates attempts to stop smoking success of attempts to stop smoking use of other aids to cessation or smoking reduction 21 Methods Monthly household surveys Each month involves a new representative sample of ~1800 respondents; smokers ~450 Data collected on electronic cigarettes since second quarter 2011 Fidler, et al., 2011. 'The smoking toolkit study': a national study of smoking and smoking cessation in England. BMC Public Health 11:479 For more info see www.smokinginengland.info 22

Percent of smokers and recent ex-smokers Prevalence of electronic cigarette use: smokers and recent ex-smokers 50 45 40 35 30 25 20 15 10 5 0 20 -2 1 1 Growth in prevalence of e-cigarette use has stalled in England

Any Daily 20 -3 1 1 20 -4 1 1 20 -1 2 1 20 -2 2

1 20 -3 2 1 20 -4 2 1 20 -1 3 1 20 -2 3 1

20 -3 3 1 20 -4 3 1 20 -1 4 1 20 -2 4 1

20 -3 4 1 N=14490 adults who smoke or who stopped in the past year; increase p<0.001 23 Electronic cigarette use 50 40 Frequency of use among users is greater in ex-smokers 30 Percent 20 10 0 Smoker

Ex-smoker N=1323 e-cigarette users not using NRT 24 Age profile of electronic cigarette users 50 45 E-cigarette use is distributed across the age range and representative of smokers 40 Percent 35 30 E-cig user Non user 25 20 15

10 5 0 16-24 25-34 35-44 45-54 55-64 65+ N=14490 adults who smoke or who stopped in the past year 25 Percent Proportion of e-cigarette users who are smokers 100 90

80 70 60 50 40 30 20 10 0 The majority of e-cigarette users also smoke -2 1-3 1-4 2-1 2-2 2-3 2-4 3-1 3-2 3-3 3-4 4-1 4-2 4-3 1 1 1 1 1 1 1 1 1 1 1

1 1 1 1 20 20 20 20 20 20 20 20 20 20 20 20 20 20 N=1745 e-cigarette users of adults who smoke or stopped in past year 26 Percent of smokers Prevalence of nicotine products while smoking 50 45 40 35 30 25 20 15 10 5 0

Increase in use of e-cigarettes while smoking has more than offset a decrease in NRT use E-cigs NRT All nicotine N=13531 smokers, increase p<0.001 e-cigs and all nicotine; decrease p=0.001 for NRT 27 P e rc e n t o f e x -s m o k e rs Prevalence of nicotine products in recent ex-smokers 70 Increase in use of e-cigarettes has more than offset a reduction in NRT use 60 50 40 30

20 E-cigs NRT All nicotine 10 0 N=959 adults who stopped in the past year; increase p<0.001 for e-cigs and all nicotine; decrease p=0.002 for NRT 28 Nicotine use by never smokers and long-term ex-smokers 4 3.5 Percent 3 Current e-cigarette use by never smokers is negligible

2.5 2 1.5 1 0.5 0 Never smoker E-cig Long-term ex-smoker NRT N=14619 never and long-term ex-smokers from Nov 2013 29 P e rc e n t s m o k in g c ig s o r u s in g n ic o tin e Prevalence of nicotine use Cigarette and nicotine show an overall decline 25 20

15 10 E-cigarette Cigarettes Nicotine or cigarettes 5 0 N=63950 adults, decrease p<0.001 for cigarettes and overall nicotine use 30 P e r c e n t w h o r e p o r t h a v in g e v e r s m o k e d Uptake of smoking Proportion of adults under 25 years who have ever smoked regularly has remained constant 100 90 80 70 60

50 40 30 20 10 0 N=11338 people aged 16-24 31 P e r c e n t w h o h a v e s m o k e d in th e p a s t y e a r w Quitting There has been an increase in the rate of quitting smoking 10 9 8 7 6 5 4 3 2

1 0 N=17045 adults who smoked in the past year; increase p<0.001 32 P e rc e n ta g e try in g to q u it in p a s t 3 m Quit attempts There has been a small increase in quit attempts 25 20 15 10 5 0 N=17045 adults who smoke or who stopped in the past 3 months; increase p=0.002 33 P e r c e n t o f s m o k e r s tr y in g to s to p Aids used in most recent quit attempt Increase in use of e-cigarettes for quitting has been

accompanied by a small reduction in use of other aids except behavioural support which has been static 50 45 40 35 30 25 20 15 10 5 0 E-cigs NRT OTC NRT Rx Champix Beh'l supp N=9438 adults who smoke and tried to stop or who stopped in the past year 34 Aids used in most recent quit attempt 100%

90% The use of either e-cigs or prescription medication has increased while use of NRTOTC or nothing has decreased and NHS support has remained static 80% 70% 60% 50% 40% 30% 20% 10% 0% 2009 2010 2011 NHS

Nothing/NRT-OTC 2012 2013 2014 Approx odds of success relative to nothing and NRT-OTC: 1.5 3.0 Med Rx/E-cigs N=9438 adults who smoke and tried to stop or who stopped in the past year; 2009 is Jul to Dec, 2014 is Jan to Sept 35 Cigarette smoking prevalence 30 24.2 25 20

22.0 21.5 Cigarette smoking prevalence continues to decline 21.4 20.7 20.0 19.3 18.5 Percent 15 10 5 0 Base: All adults Graph shows prevalence estimate and upper and lower 95% confidence intervals 36 Tried to stop smoking in past year

50 42.5 40 39.8 37.0 35.9 33.5 34.4 38.5 38.3 30 Percent 20 10 0

The rate at which smokers have tried to stop in the past year has remained relatively stable (excluding the year of smoke-free legislation) Base: Adults who smoked in the past year Graph shows prevalence estimate and upper and lower 95% confidence intervals 37 Success rate for stopping in those who tried 30 25 Percent 20 15.7 15 17.6 14.1

13.6 13.7 13.4 19.3 15.8 10 5 0 The success rate in those who have tried to stop smoking is the highest for at least 7 years Base: Smokers who tried to stop n the past year Graph shows prevalence estimate and upper and lower 95% confidence intervals 38 Conclusions In England, prevalence of e-cigarette use has remained stable for the past year at around 20% of smokers and recent ex-smokers,

with very low rates in never smokers and long-term ex-smokers There has been a substantial increase in the use of e-cigarettes as an aid to cessation which has coincided with a decline in use of less effective methods (NRT-OTC or nothing) Smoking cessation rates have increased over the time period when e-cigarette use has increased Smoking prevalence is continuing to fall Population trends conflict with the view that e-cigarettes are undermining tobacco control and instead provide reason to be cautiously optimistic about the impact of e-cigarettes in England but need to monitor closely! Acknowledgments Society for the Study of Addiction JB is funded by a SSA fellowship Co-authors: Susan Michie, Emma Beard, Daniel Kotz & Robert West CRUK, Dept of Health, Pfizer, GSK & Johnson & Johnson have all supported data collection Research team is part of the UK Centre for Tobacco and Alcohol Studies Decrease in smoking prevalence 5

4.5 4 Percent 3.5 The rate of decline in cigarette smoking prevalence has been relatively stable 3 2.5 2.1 2 1.5 1 0.5 0.5 0.6 0.7 0.8

0.8 0.2 0 Base: All adults 41 Stopped smoking in past 12 months 12 10 Percent 86.7 6 7.5 5.6 5.0

6.2 4.8 6.1 4.6 4 2 0 The smoking cessation rate in 2014 is higher at any time since 2007 Base: Adults who smoked in the past year Graph shows prevalence estimate and upper and lower 95% confidence intervals 42 P e r c a p it a d a ily c o n s u m p t io n The nicotine/cigarette market The cigarette and nicotine market are both declining

3 2.5 2 1.5 1 Nicotine Cigarettes 0.5 0 N=63842 adults Nicotine data only from last year smokers nondaily nicotine: <1 pw=0.1, 1+ pw=0.5 43

Recently Viewed Presentations

  • An Overview of SPICE - Naif

    An Overview of SPICE - Naif

    A SPICE Update(Uses animations: display using PowerPoint's "Slide Show" Mode or "Presenter View") May 2018. Charles Acton. NAIF Manager. The research described in this publication was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract...
  • Object Oriented Analyis &amp; Design Training Agenda

    Object Oriented Analyis & Design Training Agenda

    PERT Chart Gantt Chart Microsoft Project Gantt Chart Microsoft Project PERT Chart Siklus Hidup Manajemen Proyek Strategi Perencanaan Proyek Joint project planning (JPP) / Perencanaan Proyek gabungan adalah strategi tempat semua stake holder dalam proyek (para pemilik, pengguna, analisis, desainer...
  • Educator Preparation: Transforming the Profession Educator Preparation Staff

    Educator Preparation: Transforming the Profession Educator Preparation Staff

    Transmit data to PSC on a semi-annual schedule. GS3 collection and reporting is authorized in requirements of HB283, effective July 1, 2013. ... Talk about the Alliance and the fact that no other state (that we know of) has such...
  • Jeff T. Behler, Regional Director New York ... - New Jersey

    Jeff T. Behler, Regional Director New York ... - New Jersey

    Complete Count Committee. A autonomous and bi-partisan group of community leaders that are invested in the 2020 Census who come together to identify the possible obstacles and their solutions to ensure that their community is accurately represented in the 2020...
  • HighSchool

    HighSchool

    อาจารย์ ดร.วิชัย จูฑะโกสิทธิ์กานนท์ ภาควิชาธรณีวิทยา คณะ ...
  • External Examiners&#x27; Forum - University of Suffolk

    External Examiners' Forum - University of Suffolk

    External Examiners' Forum. Quality Assurance and Enhancement Team. 07 October 2016. University of Suffolk. This session was delivered on the 3rd October 2016 to those External Examiners who were able to attend the session.
  • Alzheimer&#x27;s and Dementia Resources You Can Use

    Alzheimer's and Dementia Resources You Can Use

    CMS and its partners are committed to finding new ways to implement practices that enhance the quality of life for people with dementia, protect them from substandard care and promote goal-directed, person-centered care for every nursing home resident
  • CE 394K.2 Hydrology

    CE 394K.2 Hydrology

    Example Silty-Loam soil, 30% effective saturation, rainfall 5 cm/hr intensity Neutron scattering (attenuation) Measures volumetric water content ( v) Attenuation of high-energy neutrons by hydrogen nucleus Advantages: samples a relatively large soil sphere repeatedly sample same site and several depths...